Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jingyao Gan"'
Autor:
Hanmei Li, Rui Gou, Jiaying Liao, Yao Wang, Rui Qu, Qi Tang, Jingyao Gan, Liang Zou, Sanjun Shi
Publikováno v:
Acta Materia Medica, Vol 2, Iss 1, Pp 23-41 (2023)
Rheumatoid arthritis is a systemic inflammatory disease that can lead to articular cartilage destruction and periarticular bone erosion, thus ultimately compromising joint integrity and function. Anti-inflammatory drugs and biological agents are comm
Externí odkaz:
https://doaj.org/article/db2991e41930447a983481458ecc3d2a
Autor:
Mahmoud S. Alghamri, Kaushik Banerjee, Anzar A. Mujeeb, Ava Mauser, Ayman Taher, Rohit Thalla, Brandon L. McClellan, Maria L. Varela, Svetlana M. Stamatovic, Gabriela Martinez-Revollar, Anuska V. Andjelkovic, Jason V. Gregory, Padma Kadiyala, Alexandra Calinescu, Jennifer A. Jiménez, April A. Apfelbaum, Elizabeth R. Lawlor, Stephen Carney, Andrea Comba, Syed Mohd Faisal, Marcus Barissi, Marta B. Edwards, Henry Appelman, Yilun Sun, Jingyao Gan, Rose Ackermann, Anna Schwendeman, Marianela Candolfi, Michael R. Olin, Joerg Lahann, Pedro R. Lowenstein, Maria G. Castro
Publikováno v:
ACS Nano
Glioblastoma (GBM) is an aggressive primary brain cancer; with a 5-year survival of ~5%. Challenges that hamper GBM therapeutic efficacy include: (i) tumor heterogeneity, (ii) treatment resistance, (iii) immunosuppressive tumor microenvironment (TME)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b753af4faafaed24e5ea318bc7ec661b
https://europepmc.org/articles/PMC9649873/
https://europepmc.org/articles/PMC9649873/
Publikováno v:
Journal of Controlled Release. 326:297-309
An ideal cancer vaccine should contain both strongly immunogenic cancer-specific antigen and potent adjuvant for stimulating robust cellular immunity which are pivotal for clearance of cancer cells. However, most of commercially available adjuvants s